1. Home
  2. BMRA vs SHPH Comparison

BMRA vs SHPH Comparison

Compare BMRA & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMRA
  • SHPH
  • Stock Information
  • Founded
  • BMRA 1971
  • SHPH 2012
  • Country
  • BMRA United States
  • SHPH United States
  • Employees
  • BMRA N/A
  • SHPH N/A
  • Industry
  • BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • SHPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • BMRA Health Care
  • SHPH Health Care
  • Exchange
  • BMRA Nasdaq
  • SHPH Nasdaq
  • Market Cap
  • BMRA 8.1M
  • SHPH 2.3M
  • IPO Year
  • BMRA N/A
  • SHPH 2022
  • Fundamental
  • Price
  • BMRA $3.08
  • SHPH $4.44
  • Analyst Decision
  • BMRA
  • SHPH
  • Analyst Count
  • BMRA 0
  • SHPH 0
  • Target Price
  • BMRA N/A
  • SHPH N/A
  • AVG Volume (30 Days)
  • BMRA 22.1K
  • SHPH 216.1K
  • Earning Date
  • BMRA 08-27-2025
  • SHPH 05-08-2025
  • Dividend Yield
  • BMRA N/A
  • SHPH N/A
  • EPS Growth
  • BMRA N/A
  • SHPH N/A
  • EPS
  • BMRA N/A
  • SHPH N/A
  • Revenue
  • BMRA $5,678,000.00
  • SHPH N/A
  • Revenue This Year
  • BMRA N/A
  • SHPH N/A
  • Revenue Next Year
  • BMRA N/A
  • SHPH N/A
  • P/E Ratio
  • BMRA N/A
  • SHPH N/A
  • Revenue Growth
  • BMRA 5.01
  • SHPH N/A
  • 52 Week Low
  • BMRA $1.93
  • SHPH $3.00
  • 52 Week High
  • BMRA $10.16
  • SHPH $107.40
  • Technical
  • Relative Strength Index (RSI)
  • BMRA 41.25
  • SHPH 48.65
  • Support Level
  • BMRA $3.00
  • SHPH $3.29
  • Resistance Level
  • BMRA $3.22
  • SHPH $4.10
  • Average True Range (ATR)
  • BMRA 0.18
  • SHPH 0.52
  • MACD
  • BMRA 0.00
  • SHPH 0.12
  • Stochastic Oscillator
  • BMRA 27.78
  • SHPH 37.19

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

About SHPH Shuttle Pharmaceuticals Holdings Inc.

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.

Share on Social Networks: